136 related articles for article (PubMed ID: 7811048)
1. Therapeutic efficacy of lanoconazole, a new imidazole antimycotic agent, for experimental cutaneous candidiasis in guinea pigs.
Niwano Y; Seo A; Kanai K; Hamaguchi H; Uchida K; Yamaguchi H
Antimicrob Agents Chemother; 1994 Sep; 38(9):2204-6. PubMed ID: 7811048
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic efficacy of hamycin, a polyene antimycotic agent, for experimental cutaneous candidiasis in guinea pigs.
Dhuley JN
Rocz Akad Med Bialymst; 2000; 45():19-25. PubMed ID: 11712431
[TBL] [Abstract][Full Text] [Related]
3. Short-term topical therapy of experimental tinea pedis in guinea pigs with lanoconazole, a new imidazole antimycotic agent.
Niwano Y; Tabuchi T; Kanai K; Hamaguchi H; Uchida K; Yamaguchi H
Antimicrob Agents Chemother; 1995 Oct; 39(10):2353-5. PubMed ID: 8619597
[TBL] [Abstract][Full Text] [Related]
4. [Therapeutic efficacies of neticonazole (SS717) cream and solution in experimental cutaneous Candida albicans infection of guinea pigs].
Maebashi K; Itoyama T; Uchida K; Yamaguchi H; Asaoka T; Iwasa A
Jpn J Antibiot; 1993 Oct; 46(10):896-903. PubMed ID: 8254891
[TBL] [Abstract][Full Text] [Related]
5. [Therapeutic efficacy of lanoconazole ointment in guinea pig model of tinea corporis, a comparative study with ointment and cream preparations].
Niwano Y; Tabuchi T; Kanai K; Hamaguchi H; Uchida K; Yamaguchi H
Jpn J Antibiot; 1995 Jan; 48(1):150-4. PubMed ID: 7699840
[TBL] [Abstract][Full Text] [Related]
6. A novel model of cutaneous candidiasis produced in prednisolone-treated guinea-pigs.
Maebashi K; Itoyama T; Uchida K; Suegara N; Yamaguchi H
J Med Vet Mycol; 1994; 32(5):349-59. PubMed ID: 7844701
[TBL] [Abstract][Full Text] [Related]
7. Studies on the antifungal activity of the new imidazole antimycotic lanoconazole in infected sites. Distribution in the skin and in vitro activity in the presence of stratum corneum.
Niwano Y; Matsui M; Tabuchi T; Kanai K; Hamaguchi H; Miyazaki T; Uchida K; Yamaguchi H
Arzneimittelforschung; 1997 Sep; 47(9):1056-60. PubMed ID: 9342423
[TBL] [Abstract][Full Text] [Related]
8. In vitro antifungal activity of KP-103, a novel triazole derivative, and its therapeutic efficacy against experimental plantar tinea pedis and cutaneous candidiasis in guinea pigs.
Tatsumi Y; Yokoo M; Arika T; Yamaguchi H
Antimicrob Agents Chemother; 2001 May; 45(5):1493-9. PubMed ID: 11302816
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic efficacy of lanoconazole ointment in guinea pig model of tinea pedis, in comparison with that of cream preparations].
Niwano Y; Tabuchi T; Kanai K; Hamaguchi H; Uchida K; Yamaguchi H
Jpn J Antibiot; 1994 Sep; 47(9):1192-5. PubMed ID: 7990259
[TBL] [Abstract][Full Text] [Related]
10. Wound healing effect of the new imidazole antimycotic lanoconazole in rats.
Niwano Y; Koga H; Kanai K; Hamaguchi H; Yamaguchi H
Arzneimittelforschung; 1996 Feb; 46(2):218-23. PubMed ID: 8720319
[TBL] [Abstract][Full Text] [Related]
11. In vivo activity of bifonazole in guinea pigs: its characteristic features and comparison with clotrimazole.
Yamaguchi H; Uchida K
Dermatologica; 1984; 169 Suppl 1():33-45. PubMed ID: 6526090
[TBL] [Abstract][Full Text] [Related]
12. [Studies on the in vitro antifungal activity of lanoconazole, a new topical antimycotic, against Trichophyton spp].
Niwano Y; Kanai K; Hamaguchi H; Uchida K; Yamaguchi H
Jpn J Antibiot; 1995 Jan; 48(1):146-9. PubMed ID: 7699838
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo antidermatophyte activities of NND-502, a novel optically active imidazole antimycotic agent.
Niwano Y; Kuzuhara N; Kodama H; Yoshida M; Miyazaki T; Yamaguchi H
Antimicrob Agents Chemother; 1998 Apr; 42(4):967-70. PubMed ID: 9559824
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic efficacy of latoconazole in formulations of clinical use on experimental dermatophytosis in guinea pigs.
Oka H; Niwano Y; Ohmi T; Tanaka T; Uchida M; Yamaguchi H
Arzneimittelforschung; 1992 Mar; 42(3):345-9. PubMed ID: 1497697
[TBL] [Abstract][Full Text] [Related]
15. Flutrimazole 1% dermal cream in the treatment of dermatomycoses: a multicentre, double-blind, randomized, comparative clinical trial with bifonazole 1% cream. Efficacy of flutrimazole 1% dermal cream in dermatomycoses. Catalan Flutrimazole Study Group.
Alomar A; Videla S; Delgadillo J; Gich I; Izquierdo I; Forn J
Dermatology; 1995; 190(4):295-300. PubMed ID: 7655109
[TBL] [Abstract][Full Text] [Related]
16. Antifungal activity of the new agent latoconazole in two tinea models.
Ohmi T; Konaka S; Uchida M; Yamaguchi H
Arzneimittelforschung; 1991 Aug; 41(8):847-51. PubMed ID: 1781809
[TBL] [Abstract][Full Text] [Related]
17. In vivo fungicidal effect of KP-103 in a guinea pig model of interdigital tinea pedis determined by using a new method for removing the antimycotic carryover effect.
Tatsumi Y; Yokoo M; Arika T; Yamaguchi H
Microbiol Immunol; 2002; 46(7):433-9. PubMed ID: 12222929
[TBL] [Abstract][Full Text] [Related]
18. Bilogical and toxicological properties of econazole, a broad-spectrum antimycotic.
Thienpont D; Van Cutsem J; Van Nueten JM; Niemegeers CJ; Marsboom R
Arzneimittelforschung; 1975 Feb; 25(2):224-30. PubMed ID: 1173036
[TBL] [Abstract][Full Text] [Related]
19. Bifonazole--a synopsis of clinical trials worldwide. Status and outlook.
Stettendorf S
Dermatologica; 1984; 169 Suppl 1():69-76. PubMed ID: 6241160
[TBL] [Abstract][Full Text] [Related]
20. Six novel antimycotics.
Rubin AI; Bagheri B; Scher RK
Am J Clin Dermatol; 2002; 3(2):71-81. PubMed ID: 11893219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
